[go: up one dir, main page]

AU2001289762A1 - Pharmaceutical extemporary compositions - Google Patents

Pharmaceutical extemporary compositions

Info

Publication number
AU2001289762A1
AU2001289762A1 AU2001289762A AU8976201A AU2001289762A1 AU 2001289762 A1 AU2001289762 A1 AU 2001289762A1 AU 2001289762 A AU2001289762 A AU 2001289762A AU 8976201 A AU8976201 A AU 8976201A AU 2001289762 A1 AU2001289762 A1 AU 2001289762A1
Authority
AU
Australia
Prior art keywords
extemporary
pharmaceutical
compositions
liquid
flavoured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289762A
Other languages
English (en)
Inventor
David Anthony Keating
Kurt Norman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of AU2001289762A1 publication Critical patent/AU2001289762A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001289762A 2000-07-27 2001-07-27 Pharmaceutical extemporary compositions Abandoned AU2001289762A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0018322.8A GB0018322D0 (en) 2000-07-27 2000-07-27 Pharmaceutical compositions
GB0018322 2000-07-27
PCT/EP2001/008688 WO2002009666A1 (fr) 2000-07-27 2001-07-27 Compositions pharmaceutiques impromptues

Publications (1)

Publication Number Publication Date
AU2001289762A1 true AU2001289762A1 (en) 2002-02-13

Family

ID=9896370

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289762A Abandoned AU2001289762A1 (en) 2000-07-27 2001-07-27 Pharmaceutical extemporary compositions

Country Status (7)

Country Link
EP (1) EP1303257B1 (fr)
AT (1) ATE301452T1 (fr)
AU (1) AU2001289762A1 (fr)
DE (1) DE60112584T2 (fr)
ES (1) ES2244653T3 (fr)
GB (1) GB0018322D0 (fr)
WO (1) WO2002009666A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080226795A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Non-nutritive sweetened beverages with glycerine
GB2533669B (en) * 2014-12-23 2016-12-14 Innovate Pharmaceuticals Ltd Salicylate compound composition
LT3474858T (lt) 2016-06-28 2021-12-27 Asamedic As Dviejų komponentų kompozicija, apimanti acetilsalicilo rūgštį
EP3501522A1 (fr) 2017-12-22 2019-06-26 Asamedic AS Compositions comprenant de l'acide acétylsalicylique et d'un sel de phosphate
EP3501523A1 (fr) 2017-12-22 2019-06-26 Asamedic AS Compositions à deux composants contenant de l'acide acétylsalicylique et d'un sel carbonate
KR20230048255A (ko) * 2020-05-29 2023-04-11 베디시널스 인디아 프라이빗 리미티드 Covid-19 및 연관된 장애의 관리를 위한 조성물
US20230310276A1 (en) * 2020-09-01 2023-10-05 The Global Alliance For Tb Drug Development, Inc. Methods of preparing modified dosage forms and related components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204069B (it) * 1986-05-30 1989-03-01 Menarini Sas Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
FR2686064B1 (fr) * 1992-01-15 1995-04-21 Remy Deslandes Conteneur pour la consommation d'une dose de produit liquide.
GB2272374B (en) * 1992-11-13 1996-07-03 Asta Medica Ag Stable senna extract formulations

Also Published As

Publication number Publication date
WO2002009666A1 (fr) 2002-02-07
DE60112584D1 (de) 2005-09-15
GB0018322D0 (en) 2000-09-13
ES2244653T3 (es) 2005-12-16
EP1303257B1 (fr) 2005-08-10
EP1303257A1 (fr) 2003-04-23
ATE301452T1 (de) 2005-08-15
DE60112584T2 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
MY111177A (en) Flavour-masked pharmaceutical compositions
CA2404387A1 (fr) Compositions de theanine favorisant le sommeil
WO2001085137A3 (fr) Compositions pharmaceutiques en poudre stables a base de lipides et d'ions de metaux pour l'adminsitration de medicaments et mode d'utilisation
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
DE69519300D1 (de) Stabiles arzneimittel enthaltend oxaliplatin
EP1283054A4 (fr) Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NZ501950A (en) Medicinal compositions for application to mucosa
WO2003028757A1 (fr) Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
WO2000078294A3 (fr) Forme galenique orale servant a administrer une combinaison fixe de tramadol et de diclofenac
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
WO2003049694A3 (fr) Methodes therapeutiques de traitement d'un lymphome non hodgkinien
AU2001289762A1 (en) Pharmaceutical extemporary compositions
WO2003061557A3 (fr) Compositions pharmaceutiques a base de levothyroxine, methodes de fabrication et d'administration associees
EP1023901A4 (fr) Produit d'amelioration de l'effet curatif sur l'hepatite c et son application
CA2474430A1 (fr) Polytherapie combinant un agent thrombolytique et du levosimendane pour le traitement de l'infractus aigu du myocarde
JO2492B1 (en) A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
BE2016C017I2 (fr)
EP1479387A4 (fr) Remedes contre le glaucome contenant de la bunazosine et des prostaglandines